Oova is the fertility translator that fully illuminates a woman's fertility, giving her and her care team the clearest steps to conception. Founded by doctors and backed by Mount Sinai Hospital, Oova has created a consumer-first, data-driven experience valuable to both patients and healthcare providers. Oova's at-home urine test measures both luteinizing hormone and progesterone to immediately inform a woman of her most fertile days and confirm ovulation. By delivering advanced personalized analytics and real-time action plans with every hormone reading, Oova is transforming the fertility care experience.



New York, NY, USA

Oova

BBG Ventures is a New York-based seed stage venture capital fund investing in women-led technology companies. We back founders who are creating market-defining consumer applications and services that make our lives simpler, better, more delightful.

Companies you'll love to work for